Evidence map›Paper›PMID 35796137›Full record

ArticleInvestigative and clinical urology2022

Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder.

Hye Won Lee, Ho Kyung Seo

Open access · diamondAbstract readEditorial
In one paragraph

Article in Investigative and clinical urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Hye Won LeeDepartment of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, Korea.ORCID 0000-0002-0303-4658
Ho Kyung SeoDepartment of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, Korea.ORCID 0000-0003-2601-1093
National Cancer Center · USNational Cancer Center · KR

Funding

National Cancer Center NCC2211590-1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Transitional CellUrinary Bladder NeoplasmsAdenosine Diphosphate RiboseHumansPoly(ADP-ribose) Polymerase InhibitorsUrinary BladderAdenosine Diphosphate RibosePoly(ADP-ribose) Polymerase Inhibitors

Identifiers

PMID35796137
PMCPMC9262491
OpenAlexW4284893084

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.